Class III · Lower riskRecall completed
Cyanocobalamin
Unlikely to cause harm — often a labeling or packaging issue.
Does this affect you?
Check your lot numberLots: CCC210004, Exp 09/2022; CCC210005, CCC210006, CCC210007, Exp 11/2022; CCC210010, CCC210011, Exp 04/2023.
Where it was soldNationwide in the USA.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Subpotent Drug: Out of Specification results for Assay
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
Made byAuroMedics Pharma LLC
| Brand name | CYANOCOBALAMIN |
| Generic name | CYANOCOBALAMIN |
| Active ingredient(s) | CYANOCOBALAMIN |
| Distributed by / for | Aurobindo Pharma USA Inc. |
| NDC | 55150-364-01 |
Show the full FDA record
| Full product label | Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01. |
| Recalling firm | Aurobindo Pharma USA Inc. |
| Distribution | Nationwide in the USA. |
| Quantity | 433,809 vials |
| Recall initiated | 2022-04-05 |
| Report date | 2022-04-20 |
| Recall completed | 2024-06-27 |
| Recall number | D-0766-2022 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | East Windsor NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.